Second, we did not validate the regulatory role of VISTA+ Tfr cells in in vivo ovarian cancer models (e.g., xenograft or syngeneic models), which is essential to confirm their contribution to tumor growth and immune escape in a physiological context. The gene discussed is TFRC; the disease is ovarian cancer.